- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03168204
Evaluating the Efficacy of a Detection and Prevention Program for Frail Community-dwelling Older Adults (D-SCOPE)
24 april 2019 uppdaterad av: Liesbeth De Donder, Vrije Universiteit Brussel
Study Protocol of the D-SCOPE Project With a Randomized Controlled Trial, Evaluating the Efficacy of a Detection and Prevention Program for Frail Community-dwelling Older Adults
The evaluation of a detection and prevention program which aims to create a continuum of care and support for frail community-dwelling older people (from early detection, over intervention, to follow-up).
First, the program aims to develop methods to easily, accurately and timely detect and prevent a negative frailty-balance in older people.
Second, the study aims to improve the quality and efficacy of care and support given to frail community-dwelling older people.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Faktisk)
869
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
-
Gent, Belgien, 9000
- OCMW Gent
-
Knokke-Heist, Belgien, 8300
- OCMW Knokke-Heist
-
Tienen, Belgien, 3300
- OCMW Tienen
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
60 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
Sample 1: 150 older people per municipality (total: 3 municipalities) (inclusion criteria: at least one selection criterion)
- Gender: 75 men - 75 women
- Age: 25 older people aged between 60 and 70 years old - 125 older people older than 70 years
- Marital status: 50 older people with partner - 100 older people without partner
- Living situation: 100 older people who have not moved last 10 years - 50 older people who have moved last 10 years
- Migration background: 100 older people born in Belgium - 50 older people born elsewhere
Sample 2: 150 older people per municipality (total: 3 municipalities) (inclusion criteria: all selection criteria at once)
- 75 men, older than 70 years, living together/widowed/divorced/never married, moved last 10 years
- 75 women, older than 70 years, widowed/divorced/never married, moved last 10 years
Exclusion Criteria:
- Current institutionalization
- Current hospitalization
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Fyrdubbla
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Risk of being frail experimental group
|
Offering tailored care and support whereby the competences, strengths and resources of the older person are taken into account.The intervention will be an enhancement of usual care and will depend on the availability of the municipality, and could be formal (i.e., home care) or informal (e.g.
activities of an older adult's association).
|
|
Inget ingripande: Risk of being frail control group
|
|
|
Inget ingripande: No/low risk of being frail
|
|
|
Inget ingripande: Risk of being frail care avoiders
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change from baseline Quality of Life at 6 months
Tidsram: Assessed during baseline testing + 6 months after inclusion
|
One question from the WHOQOL-BREF will be used to measure the quality of life of participants (1 item).
Older participants will also be asked to rate their quality of life on a scale from 0 to 10.
|
Assessed during baseline testing + 6 months after inclusion
|
|
Change from baseline Satisfaction with Life at 6 months
Tidsram: Assessed during baseline testing + 6 months after inclusion
|
The Satisfaction with Life Scale will be administered to explore the life satisfaction of the participants (5 items)
|
Assessed during baseline testing + 6 months after inclusion
|
|
Change from baseline sense of mastery at 6 months
Tidsram: Assessed during baseline testing + 6 months after inclusion
|
To assess the sense of mastery of older people, the current mastery questionnaire will be used and one self-constructed item will be added which will assess mastery in relation to others.
Older participants will also be asked to rate their mastery on a scale from 0 to 10.
|
Assessed during baseline testing + 6 months after inclusion
|
|
Change from baseline Meaning in Life at 6 months
Tidsram: Assessed during baseline testing + 6 months after inclusion
|
Meaning in life will be evaluated with 5 items from the Meaning in Life Questionnaire (MLQ).
Older participants will also be asked to rate their meaning in life on a scale from 0 to 10.
|
Assessed during baseline testing + 6 months after inclusion
|
|
Change from baseline Community Inclusion at 6 months
Tidsram: Assessed during baseline testing + 6 months after inclusion
|
Community inclusion will be measured using 1 item from the Community Integration Measure (CIM).
Older participants will also be asked to rate their community inclusion on a scale from 0 to 10.
|
Assessed during baseline testing + 6 months after inclusion
|
|
Change from baseline aging well in place at 6 months
Tidsram: Assessed during baseline testing + 6 months after inclusion
|
One self-constructed question (1 item) will assess if the older person lives at home in a qualitative manner
|
Assessed during baseline testing + 6 months after inclusion
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Multidimensional frailty
Tidsram: Assessed during baseline testing + 6 months after inclusion
|
The Comprehensive Frailty Assessment Instrument (CFAI) will be used to measure multidimensional frailty: physical, cognitive, psychological, social and environmental frailty
|
Assessed during baseline testing + 6 months after inclusion
|
|
Physical phenotype of frailty
Tidsram: Assessed during baseline testing + 6 months after inclusion
|
The Fried's phenotype of frailty will be used to assess the physical phenotype of frailty as well as the questionnaire of Op het Veld
|
Assessed during baseline testing + 6 months after inclusion
|
|
Feeling frail
Tidsram: Assessed during baseline testing + 6 months after inclusion
|
The subjective feeling of frailty will be assessed using 1 self-constructed question and will assess to what extent an older person feels frail
|
Assessed during baseline testing + 6 months after inclusion
|
|
Resilience
Tidsram: Assessed during baseline testing + 6 months after inclusion
|
Resilience will be measured using the Connor-Davidson Resilience Scale (CD-RISC2), which is an abbreviated 2-item version of the original scale
|
Assessed during baseline testing + 6 months after inclusion
|
|
Coping
Tidsram: Assessed during baseline testing + 6 months after inclusion
|
Coping will be measured using 12 items from the BRIEF cope.
Two items from active coping, positive reframing, religion, use of emotional support and self-distraction and one item from acceptance and behavioral disengagement will be used
|
Assessed during baseline testing + 6 months after inclusion
|
|
Help needed for activities in daily life
Tidsram: Assessed during baseline testing + 6 months after inclusion
|
Older people will be asked if they need help with 8 activities of daily life, and to what extent the help they receive for these activities is sufficient.
These questions are adapted from the questionnaire of the Belgian Ageing Studies (BAS)
|
Assessed during baseline testing + 6 months after inclusion
|
|
Informal and formal care
Tidsram: Assessed during baseline testing + 6 months after inclusion
|
Older people will be asked if they receive care from 6 informal and 14 formal caregivers and if they are satisfied with the help they receive from these caregivers.
These questions are adapted from the BAS-questionnaire.
|
Assessed during baseline testing + 6 months after inclusion
|
|
Medical care
Tidsram: Assessed during baseline testing + 6 months after inclusion
|
The participants will be asked if they needed to go to the hospital, to a residential setting and a rehabilitation center over the past 6 months (day case/overnight stay).
These questions are adapted from the Health Interview Survey.
In addition, the participants will be asked when they visited the general practitioner for the last time over the last 6 months.
|
Assessed during baseline testing + 6 months after inclusion
|
|
Leisure time
Tidsram: Assessed during baseline testing + 6 months after inclusion
|
Leisure time will be measured by using an adapted question with 8 items derived from the BAS-questionnaire and will examine how often the participants perform the listed activities
|
Assessed during baseline testing + 6 months after inclusion
|
|
Neighborhood
Tidsram: Assessed during baseline testing + 6 months after inclusion
|
Different dimensions of neighborhood will be assessed.
First, the social environment will be administered by using 3 items from the social cohesion dimension of the Neighbourhood Scale.
Second, the physical environment will be explored by using 4 items from the BAS-questionnaire as well as from the Neighbourhood Environment Walkability Scale.
Finally, low-key participation will be examined by using 2 items from the questionnaire of Oswald & Konopik.
|
Assessed during baseline testing + 6 months after inclusion
|
|
Life-events
Tidsram: Assessed during baseline testing + 6 months after inclusion
|
A shortened version of the Geriatric Adverse Life Events Scale (GALES) will be adapted to assess to occurrence of life-events (11 items)
|
Assessed during baseline testing + 6 months after inclusion
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Liesbeth De Donder, Prof. Dr., Vrije Universiteit Brussel
Publikationer och användbara länkar
Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
1 juni 2017
Primärt slutförande (Faktisk)
30 april 2018
Avslutad studie (Faktisk)
30 juni 2018
Studieregistreringsdatum
Först inskickad
17 maj 2017
Först inskickad som uppfyllde QC-kriterierna
23 maj 2017
Första postat (Faktisk)
30 maj 2017
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
25 april 2019
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
24 april 2019
Senast verifierad
1 april 2019
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- D-SCOPE IWT 140027
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Äldre vuxna
-
Nanjing Medical UniversityRekryteringAdult Attention Deficit Hyperactivity DisorderKina
-
Rochester Center for Behavioral MedicineShireAvslutadAdult Attention-Deficit Hyperactivity DisorderFörenta staterna
-
NYU Langone HealthCorium, Inc.AvslutadVaraktighet och effekt av Azstarys på vuxna ADHD-symtom och verkställande funktion tidigt på kvällenAdult Attention Deficit Hyperactivity DisorderFörenta staterna
-
Universität des SaarlandesAvslutadAdult Attention Deficit Hyperactivity DisorderTyskland
-
SunovionAvslutadAdult Attention Deficit Hyperactivity DisorderFörenta staterna
-
Otsuka Pharmaceutical Development & Commercialization...AvslutadAdult Attention Deficit Hyperactivity DisorderFörenta staterna
-
SunovionAvslutadAdult Attention Deficit Hyperactivity DisorderFörenta staterna
-
Gaia AGUniversity Hospital, Saarland; Zentrum für Integrative Psychiatrie KielAvslutadAdult Attention Deficit Hyperactivity DisorderTyskland
-
Otsuka Pharmaceutical Development & Commercialization...AvslutadAdult Attention-Deficit Hyperactivity Disorder (ADHD)Australien
-
SunovionAvslutad
Kliniska prövningar på Tailored care and support
-
Seattle Children's HospitalRekryteringHuvudvärk | Hjärnskakning | Lätt traumatisk hjärnskadaFörenta staterna
-
Columbia UniversityNational Institute on Minority Health and Health Disparities (NIMHD)RekryteringModerns död | Maternal komplikation av graviditetFörenta staterna
-
March of Dimes, CanadaHamilton Health Sciences CorporationAvslutad
-
Northwestern UniversityRekryteringAkut lymfoblastisk leukemi | Lymfoblastiskt lymfomFörenta staterna
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Avslutad
-
Oregon Health and Science UniversityNational Institute on Aging (NIA)AvslutadDemens | Alzheimers sjukdom | Familjemedlemmar | Vårdgivarens utbrändhetFörenta staterna
-
Omada Health, Inc.Palo Alto Medical Foundation; Sutter HealthAvslutadDiabetes typ 2Förenta staterna
-
Karolinska InstitutetAvslutad
-
University of ArkansasIndragenDiabetes mellitus, typ 2 | SömnhygienFörenta staterna
-
Susan MagasiNorthwestern University Feinberg School of Medicine; Shirley Ryan AbilityLabHar inte rekryterat ännu